Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), as part of the evolution path initiated in 2024 and continued in 2025, confirms its commitment to strengthening ...

Integrated risk management (IRM) is becoming an increasingly popular term to showcase the importance of risk at the forefront of corporate governance, as well as inferring that, traditionally, these ...

ROME, April 03, 2026--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), as part of the evolution path initiated in 2024 and continued ...

Feasibility of Weekly Electronic Health Record–Embedded Patient-Reported Outcomes for Patients Starting Oral Cancer–Directed Therapy The ELAINE 2 study (ClinicalTrials.gov identifier: NCT04432454) is ...